EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus

Dyah Purnamasari, Erpryta Nurdia Tetrasiwi, Gracia Jovita Kartiko, Cindy Astrella, Khoirul Husam, Purwita Wijaya Laksmi

Review of Diabetic Studies · 28.09.2022 · 18 (3) · 157-165

DOI: 10.1900/rds.2022.18.157 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Review of Diabetic Studies, erschienen am 28.09.2022. Verfasst von Dyah Purnamasari und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Division of Endocrinology Metabolism and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Me…. Hauptthemen laut MEDLINE: Sarcopenia, Diabetes Mellitus, Type 2, Insulin Resistance. Die Arbeit wurde bisher 133-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sarcopenia, defined as the loss of skeletal muscle mass and strength and/or a decrease in physical performance, is classically related to aging. However, chronic disease, including type 2 diabetes mellitus (T2DM), may accelerate the development of sarcopenia. Previous studies found strong association between T2DM and sarcopenia. Insulin resistance that exists in T2DM is thought to be the key mediator for impaired physical function and mobility which may lead to sarcopenia. T2DM may cause sarcopenia through the mediation of insulin resistance, inflammation, accumulation of advanced glycation end-products, and oxidative stress that may affect muscle mass and strength, protein metabolism, and vascular and mitochondrial dysfunction. On the other hand, loss of muscle in sarcopenia may play a role in the development of T2DM through the decreased production of myokines that play a role in glucose and fat metabolism. This review highlights the findings of existing literature on the relationship between T2DM and sarcopenia which emphasize the pathophysiology, chronic vascular complications, and the course of macrovascular and microvascular complications in T2DM.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SarcopeniaDiabetes Mellitus, Type 2Insulin ResistanceHumansRisk FactorsMuscle, Skeletal

Autor:innen und Institutionen

  • 1Division of Endocrinology Metabolism and Diabetes, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • 3Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.
  • 4Division of Geriatric, Department of Internal Medicine, Dr. Cipto Mangunkusumo National Referral Hospital, Faculty of Medicine, Universitas Indonesia, Jakarta, Indonesia.

Zitieren

APA

Purnamasari, D., Tetrasiwi, E. N., Kartiko, G. J., Astrella, C., Husam, K., & Laksmi, P. W. (2022). Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus. Review of Diabetic Studies, 18(3), 157-165. https://doi.org/10.1900/rds.2022.18.157

Vancouver

Purnamasari D, Tetrasiwi EN, Kartiko GJ, Astrella C, Husam K, Laksmi PW. Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus. Review of Diabetic Studies. 2022;18(3):157-165. doi:10.1900/rds.2022.18.157

BibTeX
@article{Purnamasari2022,
  author = {Purnamasari, Dyah and Tetrasiwi, Erpryta Nurdia and Kartiko, Gracia Jovita and Astrella, Cindy and Husam, Khoirul and Laksmi, Purwita Wijaya},
  title = {Sarcopenia and Chronic Complications of Type 2 Diabetes Mellitus},
  journal = {Review of Diabetic Studies},
  year = {2022},
  volume = {18},
  number = {3},
  pages = {157--165},
  doi = {10.1900/rds.2022.18.157}
}
Kostenlos starten →